Serial Number:
79270919
Mark:
RAYHUNTA
Status:
Registered
Status Date:
12-01-2020
Filing Date:
Registration Number:
6207918
Registration Date:
12-01-2020
Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Fabry disease, Gaucher disease, GM1 Gangliosidosis, GM2 Gangliosidosis, Krabbe disease, Niemann-Pick disease, Metachromatic leukodystrophy, Hurier syndrome, Hunter disease, Sanfilippo syndrome, Morquio syndrome, Sly syndrome, Pompe disease, Alfa-mannosidosis disease, Fucosidosis disease, and Neuronal ceroid lipofuscinosis
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
09-15-2020
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
OBLON MCCLELLAND MAIER & NEUSTADT LLP
Correspondent Name:
